Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Newmont Corporation (NEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs Newmont Corporation — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.18B), while Newmont Corporation trades at $113.24 (market cap $121.80B). The key difference: Newmont Corporation is far larger — about 29.1× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Newmont Corporation pays a 0.9% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Newmont Corporation for 59 Days on average.
| INDV | NEM | |
|---|---|---|
Market Cap | $4.18B | $121.80B |
Volume | 1,819,746 | 4,383,120 |
Sector | Health | Basic Materials |
52-Week High | $41.83 | $135.14 |
52-Week Low | $24.09 | $78.63 |
Typical Hold Time | 0 Days | 59 Days |
Enterprise Value | $4.47B | $118.39B |
Dividend Yield | — | 0.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Newmont Corporation (NEM) trades at $115.59, down 1.33% on the day, as the gold mining giant demonstrates strong fundamental performance with record revenue of $22.67 billion in 2025 and net income of $7.09 billion. The stock shows a bullish technical trend with support at $115 and resistance at $118, while maintaining attractive valuation metrics including a P/E of 14.58 and ROE of 25.53%. Recent news highlights the company's record $5.3 billion free cash flow and focus on per-share growth through operational improvements.
Newmont presents a compelling investment case with strong analyst support (76% buy ratings) and a $136.83 consensus price target representing 18% upside. The company's transformation from losses in 2022-2023 to robust profitability, coupled with disciplined capital allocation and gold price tailwinds, supports continued growth. Key risks include gold price volatility, operational execution challenges, and broader market conditions that could pressure mining stocks despite strong fundamentals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →
